Morgens Waterfall Vintiadis & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,300
| Closed | -$3.47M | – | 29 |
|
|
2024
Q3 | $3.47M | Hold |
3,300
| – | – | 2.69% | 19 |
|
|
2024
Q2 | $3.47M | Sell |
3,300
-600
| -15% | -$631K | 2.64% | 22 |
|
|
2024
Q1 | $3.75M | Sell |
3,900
-200
| -5% | -$192K | 2.59% | 20 |
|
|
2023
Q4 | $3.6M | Buy |
4,100
+2,600
| +173% | +$2.28M | 2.68% | 20 |
|
|
2023
Q3 | $1.23M | Hold |
1,500
| – | – | 1% | 25 |
|
|
2023
Q2 | $1.08M | Hold |
1,500
| – | – | 0.77% | 27 |
|
|
2023
Q1 | $1.23M | Hold |
1,500
| – | – | 1.01% | 29 |
|
|
2022
Q4 | $1.08M | Buy |
1,500
+400
| +36% | +$289K | 0.94% | 34 |
|
|
2022
Q3 | $758K | Buy |
+1,100
| New | +$758K | 0.83% | 31 |
|
|
2022
Q2 | – | Sell |
-3,900
| Closed | -$2.72M | – | 33 |
|
|
2022
Q1 | $2.72M | Buy |
+3,900
| New | +$2.72M | 1.71% | 20 |
|
|
2021
Q4 | – | Sell |
-3,500
| Closed | -$2.12M | – | 34 |
|
|
2021
Q3 | $2.12M | Hold |
3,500
| – | – | 1.09% | 25 |
|
|
2021
Q2 | $1.96M | Buy |
+3,500
| New | +$1.96M | 1% | 28 |
|